We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

139 hedge funds and large institutions have $1.18B invested in Nektar Therapeutics in 2013 Q2 according to their latest regulatory filings, with 139 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

687% more call options, than puts

Call options by funds: $12.7M | Put options by funds: $1.62M

Holders
139
Holders Change
+139
Holders Change %
–
% of All Funds
4.54%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
139
Increased
–
Reduced
–
Closed
–
Calls
$12.7M
Puts
$1.62M
Net Calls
+$11.1M
Net Calls Change
+$11.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OppenheimerFunds
New York
$262M +$232M +1,513,333 New
Primecap Management
2
Primecap Management
California
$87.5M +$77.5M +504,990 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$78.8M +$69.8M +454,936 New
Federated Hermes
4
Federated Hermes
Pennsylvania
$72.2M +$63.9M +416,567 New
HM
5
HealthCor Management
New York
$46.2M +$40.9M +266,667 New
BFA
6
BlackRock Fund Advisors
California
$43.8M +$38.8M +253,044 New
BIT
7
BlackRock Institutional Trust
California
$38M +$33.6M +219,096 New
State Street
8
State Street
Massachusetts
$35.4M +$31.3M +204,283 New
Bank of New York Mellon
9
Bank of New York Mellon
New York
$34.5M +$30.5M +198,981 New
DM
10
Deerfield Management
New York
$34M +$30.1M +195,983 New
GIM
11
Granahan Investment Management
Massachusetts
$33.3M +$29.5M +192,413 New
AG
12
Artal Group
Luxembourg
$28.9M +$25.6M +166,667 New
First Trust Advisors
13
First Trust Advisors
Illinois
$25.8M +$22.8M +148,713 New
JP Morgan Chase
14
JP Morgan Chase
New York
$24.6M +$21.7M +141,785 New
NMC
15
NEA Management Company
Maryland
$21.1M +$18.7M +121,707 New
Northern Trust
16
Northern Trust
Illinois
$19.1M +$16.9M +110,130 New
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$17.5M +$15.5M +100,927 New
MG
18
Meditor Group
Bermuda
$16.7M +$14.8M +96,667 New
SFM
19
Systematic Financial Management
New Jersey
$16.6M +$14.7M +96,005 New
JHIU
20
Janus Henderson Investors US
Colorado
$15.5M +$13.7M +89,212 New
Franklin Resources
21
Franklin Resources
California
$14.4M +$12.7M +82,840 New
TCM
22
Tang Capital Management
California
$10.5M +$9.32M +60,737 New
PAM
23
Panagora Asset Management
Massachusetts
$10.5M +$9.26M +60,364 New
ICM
24
IronBridge Capital Management
Illinois
$9.46M +$8.38M +54,634 New
SCA
25
SAC Capital Advisors
Connecticut
$9.35M +$8.28M +53,972 New
1
2 3 4 5

NKTR Hedge Fund Activity: Q2 2013 in Review

139 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q2 2013, worth a combined $1.18B.

Buyers outnumbered sellers: 139 funds opened new NKTR positions and 0 closed out — a net gain of 139 holders — while 0 added to existing stakes and 0 trimmed.

  • 139 institutional investors held Nektar Therapeutics (NKTR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.18B of Nektar Therapeutics stock for Q2 2013.
  • 139 funds opened new Nektar Therapeutics positions in Q2 2013 and 0 closed out, a net change of +139 holders.

Based on aggregated 13F filings for Q2 2013.